- Treasury weighs screening investments in China biotechOfficials at the Treasury Department are looking at potential restrictions on US investments in China biotech, according to multiple sources familiar with the discussions. At least two sources to…Endpoints · 1mo ago↗ source
- cAMPfield lands $180M to build gut disease drug<figure><div><img src="https://imgproxy.divecdn.com/4eoVQHFTAvljHZA3dtwvKrrS1WlgcrV7_wLUFGcZYWw/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMjMwMTMxMDIyXzEua…BioPharma Dive · 1mo ago↗ source
- Novo Nordisk expands in China and Czech; Cellares boosts Series D by $50MPlus more from Eisai and Siegfried. 🧱 Novo Nordisk's expansions: Novo Nordisk has invested around $380 million to expand its manufacturing facility in Bohumil, Central Bohemia, in the Czech Repu…